Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
BMC Infectious Diseases
|
April 17, 2016
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
L Boiron, E Joura, N Largeron, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
September 1, 1995
Differential diagnosis of detrusor instability and stress-incontinence by patient history: the Gaudenz-Incontinence-Questionnaire revisited
G Haeusler, E Hanzal, E Joura, et al.
Oncology Reports
|
May 19, 2011
Psychological burden of women with mild cervical intraepithelial neoplasia
H Zeisler, K Mayerhofer, E Joura, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1997
Successful treatment of a high-risk choriocarcinoma in Figo stage IV (WHO score 12)
P Frigo, C Lang, E Joura, et al.
Vaccine
|
October 26, 2010
Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine
J Monsonego, J Cortes, C Greppe, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1992
[Delivery in status post sectio 1976-1991]
C Kainz, G Gitsch, E Joura, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1992
[Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer]
E Joura, G Gitsch, C Kainz, et al.
Anticancer Research
|
July 1, 1992
Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer
G Gitsch, C Kainz, E Joura, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie
|
May 1, 1993
[Obstetric management of patients with HELLP syndrome]
G Sliutz, B Schäfer, R Obwegeser, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
BMC Infectious Diseases
|
April 17, 2016
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
L Boiron, E Joura, N Largeron, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
September 1, 1995
Differential diagnosis of detrusor instability and stress-incontinence by patient history: the Gaudenz-Incontinence-Questionnaire revisited
G Haeusler, E Hanzal, E Joura, et al.
Oncology Reports
|
May 19, 2011
Psychological burden of women with mild cervical intraepithelial neoplasia
H Zeisler, K Mayerhofer, E Joura, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1997
Successful treatment of a high-risk choriocarcinoma in Figo stage IV (WHO score 12)
P Frigo, C Lang, E Joura, et al.
Vaccine
|
October 26, 2010
Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine
J Monsonego, J Cortes, C Greppe, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1992
[Delivery in status post sectio 1976-1991]
C Kainz, G Gitsch, E Joura, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1992
[Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer]
E Joura, G Gitsch, C Kainz, et al.
Anticancer Research
|
July 1, 1992
Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer
G Gitsch, C Kainz, E Joura, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie
|
May 1, 1993
[Obstetric management of patients with HELLP syndrome]
G Sliutz, B Schäfer, R Obwegeser, et al.
Page
of 2